JPH10507085A5 - - Google Patents

Info

Publication number
JPH10507085A5
JPH10507085A5 JP1997502170A JP50217097A JPH10507085A5 JP H10507085 A5 JPH10507085 A5 JP H10507085A5 JP 1997502170 A JP1997502170 A JP 1997502170A JP 50217097 A JP50217097 A JP 50217097A JP H10507085 A5 JPH10507085 A5 JP H10507085A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997502170A
Other languages
English (en)
Japanese (ja)
Other versions
JP4294092B2 (ja
JPH10507085A (ja
Filing date
Publication date
Priority claimed from US08/479,916 external-priority patent/US5741677A/en
Application filed filed Critical
Publication of JPH10507085A publication Critical patent/JPH10507085A/ja
Publication of JPH10507085A5 publication Critical patent/JPH10507085A5/ja
Application granted granted Critical
Publication of JP4294092B2 publication Critical patent/JP4294092B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP50217097A 1995-06-07 1996-06-06 テロメア長を測定するための方法 Expired - Lifetime JP4294092B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/479,916 US5741677A (en) 1995-06-07 1995-06-07 Methods for measuring telomere length
US08/479,916 1995-06-07
PCT/US1996/010035 WO1996041016A1 (en) 1995-06-07 1996-06-06 Methods for measuring telomere length

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007329366A Division JP2008119005A (ja) 1995-06-07 2007-12-20 テロメア長を測定するための方法

Publications (3)

Publication Number Publication Date
JPH10507085A JPH10507085A (ja) 1998-07-14
JPH10507085A5 true JPH10507085A5 (cg-RX-API-DMAC7.html) 2004-07-08
JP4294092B2 JP4294092B2 (ja) 2009-07-08

Family

ID=23905964

Family Applications (2)

Application Number Title Priority Date Filing Date
JP50217097A Expired - Lifetime JP4294092B2 (ja) 1995-06-07 1996-06-06 テロメア長を測定するための方法
JP2007329366A Pending JP2008119005A (ja) 1995-06-07 2007-12-20 テロメア長を測定するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2007329366A Pending JP2008119005A (ja) 1995-06-07 2007-12-20 テロメア長を測定するための方法

Country Status (7)

Country Link
US (2) US5741677A (cg-RX-API-DMAC7.html)
EP (1) EP0774014A4 (cg-RX-API-DMAC7.html)
JP (2) JP4294092B2 (cg-RX-API-DMAC7.html)
AU (1) AU697882B2 (cg-RX-API-DMAC7.html)
CA (1) CA2196898C (cg-RX-API-DMAC7.html)
MX (1) MX9700950A (cg-RX-API-DMAC7.html)
WO (1) WO1996041016A1 (cg-RX-API-DMAC7.html)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69637086T2 (de) * 1995-10-12 2008-01-10 Lansdorp, Peter M., Vancouver Verfahren zum nachweis von mehrfachkopien einer wiederholungssequenz in einem nukleinsäuremolekül
ES2319238T3 (es) 1996-07-01 2009-05-05 Gemin X Pharmaceuticals Canada Inc. Composiciones para modular la longitud de los talomeros.
GB2321642B8 (en) 1996-10-01 2006-08-22 Geron Corp Human telomerase reverse transcriptase promoter
US6117634A (en) 1997-03-05 2000-09-12 The Reagents Of The University Of Michigan Nucleic acid sequencing and mapping
US6197557B1 (en) 1997-03-05 2001-03-06 The Regents Of The University Of Michigan Compositions and methods for analysis of nucleic acids
US5871926A (en) * 1997-04-21 1999-02-16 The University Of New Mexico Sensitive method for measurement of telomeric DNA content in human tissues
JP4013333B2 (ja) * 1998-06-05 2007-11-28 株式会社B&Cラボラトリーズ 皮膚の老化度の測定方法および測定用キット
US7981599B1 (en) 1998-07-31 2011-07-19 Boston Probes, Inc. Non-nucleic acid probes, probe sets, methods and kits pertaining to the detection of individual human chromosomes X, Y, 1, 2, 3, 4, 6, 7, 8, 9, 10, 11, 12, 16, 17, 18 and 20 as 13/21 as a pair
US7270958B2 (en) 1998-09-10 2007-09-18 The Regents Of The University Of Michigan Compositions and methods for analysis of nucleic acids
US6280947B1 (en) 1999-08-11 2001-08-28 Exact Sciences Corporation Methods for detecting nucleotide insertion or deletion using primer extension
US6503718B2 (en) 1999-01-10 2003-01-07 Exact Sciences Corporation Methods for detecting mutations using primer extension for detecting disease
US7960540B2 (en) * 1999-04-08 2011-06-14 Advanced Cancer Therapeutics, Llc Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
US20080318890A1 (en) * 1999-04-08 2008-12-25 Antisoma Research Limited Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
CA2370000A1 (en) * 1999-04-08 2000-10-19 Uab Research Foundation Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin
US20080318889A1 (en) * 1999-04-08 2008-12-25 Antisoma Research Limited Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
US8114850B2 (en) * 1999-04-08 2012-02-14 Advanced Cancer Therapeutics, Llc Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
US6995145B1 (en) 1999-06-04 2006-02-07 Au Jessie L-S Methods and compositions for modulating drug activity through telomere damage
WO2000074667A2 (en) * 1999-06-04 2000-12-14 Au Jessie L S Compositions active in telomere damage comprising a taxane and telomerase inhibitor
GB0005281D0 (en) * 2000-03-07 2000-04-26 Secr Defence Analytical method
GB0009784D0 (en) * 2000-04-20 2000-06-07 Simeg Limited Methods for clinical diagnosis
EP1399591A2 (en) * 2001-06-23 2004-03-24 University of Wales College of Medicine Method for the determination of telomere length
US20030124549A1 (en) * 2001-10-11 2003-07-03 Xerox Corporation Devices and methods for detecting genetic sequences
DE10161829B4 (de) * 2001-12-15 2006-02-16 Peter Lahnert Neue Methode zur Bestimmung der Telomerlänge und ihre Verwendung zur Abschätzung des Lebensalters
ES2379375T3 (es) * 2002-01-31 2012-04-25 University Of Utah Amplificación de secuencias repetitivas de ácido nucleico
US7776524B2 (en) 2002-02-15 2010-08-17 Genzyme Corporation Methods for analysis of molecular events
US6916621B2 (en) 2002-03-27 2005-07-12 Spectral Genomics, Inc. Methods for array-based comparitive binding assays
US20040234961A1 (en) * 2002-04-22 2004-11-25 Fordyce Colleen A. Telomere length determination and applications
GB0214842D0 (en) * 2002-06-27 2002-08-07 Simeg Ltd Diagnostic method
WO2004035597A2 (en) * 2002-10-16 2004-04-29 Women And Infants Hospital Of Rhode Island, Inc. Methods of assessing the risk of reproductive failure by measuring telomere length
KR100479264B1 (ko) * 2002-11-01 2005-03-28 한국전자통신연구원 주기적 가열과 냉각을 통한 혼성화 방법 및 이를 사용하는폴리뉴클레오타이드 검출 장치
EP3351919A1 (en) 2003-01-24 2018-07-25 University of Utah Methods of predicting mortality risk by determining telomere length
WO2004106490A2 (en) * 2003-05-28 2004-12-09 The Johns Hopkins University NOVEL METHODS FOR FINDING MUTATIONS CAUSED BY THE INSERTION OF REPETEAD DNAs
US20080108057A1 (en) * 2004-06-22 2008-05-08 Griffith Jeffrey K Allelic imbalance in the diagnosis and prognosis of cancer
US7981607B2 (en) 2004-08-27 2011-07-19 Esoterix Genetic Laboratories LLC Method for detecting recombinant event
WO2006047787A2 (en) 2004-10-27 2006-05-04 Exact Sciences Corporation Method for monitoring disease progression or recurrence
US9777314B2 (en) 2005-04-21 2017-10-03 Esoterix Genetic Laboratories, Llc Analysis of heterogeneous nucleic acid samples
WO2008119027A2 (en) * 2007-03-27 2008-10-02 The Johns Hopkins University Genetic testing of telomere-associated genes in dyskeratosis congenita and related disorders
EP2191013A1 (en) * 2007-08-10 2010-06-02 Tina Holding APS Method for estimating telomere length
US20090131351A1 (en) * 2007-11-16 2009-05-21 Antisoma Research Limited Methods, compositions, and kits for modulating tumor cell proliferation
US8084203B2 (en) 2008-05-12 2011-12-27 Fundacion Centro Nacional De Investigaciones Oncologicas Carlos Iii Methods for the determination of telomere length in a semi-automatic manner of every single cell in a immobilized cell population
CA2723950C (en) * 2008-05-12 2016-07-12 Fundacion Centro Nacional De Investigaciones Oncologicas Carlos Iii Methods and reagents for the determination of telomere length in a semi-automatic manner of every single cell in a immobilized cell population
US20090298709A1 (en) * 2008-05-28 2009-12-03 Affymetrix, Inc. Assays for determining telomere length and repeated sequence copy number
LT3029154T (lt) 2008-10-17 2017-12-27 Geron Corporation Paciento jautrumo telomerazės slopinimo terapijai nustatymo būdas
EP2379747B1 (en) 2008-12-22 2013-07-03 University of Utah Research Foundation Monochrome multiplex quantitative pcr
AU2010314980A1 (en) * 2009-11-06 2012-05-24 Enzymatics, Inc. Composition and method for synthesizing a deoxyribonucleotide chain using a double stranded nucleic acid complex with a thermostable polymerase
WO2012027547A2 (en) * 2010-08-25 2012-03-01 Columbia University Quantitative total definition of biologically active sequence elements
US20120196284A1 (en) * 2010-12-16 2012-08-02 University Of Medicine And Dentistry Of New Jersey Method of Measuring Telomere Length
RU2508407C9 (ru) * 2012-10-10 2014-05-20 Елена Андреевна Чирясова Способ количественной оценки терминальных нуклеотидов g-цепи теломерной днк человека с помощью полимеразной цепной реакции и дуплекс-специфического анализа, наборы синтетических олигонуклеотидных праймеров и зондов для осуществления этого способа
US9200327B2 (en) 2012-11-30 2015-12-01 Geron Corporation Diagnostic markers for treating cell proliferative disorders with telomerase inhibitors
ES2827248T3 (es) * 2013-03-15 2021-05-20 Elixirgen Therapeutics Inc Métodos de uso de Zscan4 para rejuvenecer células humanas
WO2014190138A2 (en) * 2013-05-22 2014-11-27 Telomere Diagnostics, Inc. Measures of short telomere abundance
EP3068435A1 (en) 2013-11-13 2016-09-21 Novartis AG Mtor inhibitors for enhancing the immune response
EP4420663A3 (en) 2013-12-20 2024-10-30 Novartis AG Regulatable chimeric antigen receptor
EP3193915A1 (en) 2014-07-21 2017-07-26 Novartis AG Combinations of low, immune enhancing. doses of mtor inhibitors and cars
WO2016014553A1 (en) 2014-07-21 2016-01-28 Novartis Ag Sortase synthesized chimeric antigen receptors
KR102255304B1 (ko) 2014-09-26 2021-05-24 삼성전자주식회사 텔로미어 증폭 방법
GB201418144D0 (en) 2014-10-14 2014-11-26 Univ Cardiff High throughput sequencing
JP2018501799A (ja) 2014-12-30 2018-01-25 テロメア ダイアグノスティクス インコーポレイテッド マルチプレックス定量的pcr
WO2016149618A1 (en) * 2015-03-19 2016-09-22 The Johns Hopkins University Method for regulation of telomere-length
US10576076B2 (en) 2015-05-20 2020-03-03 Novartis Ag Pharmaceutical combination of everolimus with dactolisib
US10441584B2 (en) 2016-11-23 2019-10-15 Novartis Ag Methods of enhancing immune response
CN106755429A (zh) * 2016-12-27 2017-05-31 上海三誉生物科技有限公司 一种精确测量人群端粒长度的方法
SG11201909924VA (en) 2017-05-02 2019-11-28 Revolution Medicines Inc Rapamycin analogs as mtor inhibitors
US20200385789A1 (en) * 2017-09-01 2020-12-10 Children's Medical Research Institute Methods of assessing telomeres
US10098922B1 (en) 2017-11-30 2018-10-16 Optigenex, Inc. Increasing telomere length in a cell
US10596165B2 (en) 2018-02-12 2020-03-24 resTORbio, Inc. Combination therapies
FI3788049T3 (fi) 2018-05-01 2023-05-30 Revolution Medicines Inc C40-, c28- ja c-32-liittyneitä rapamysiinianalogeja mtor-estäjinä
SG11202010560QA (en) 2018-05-01 2020-11-27 Revolution Medicines Inc C26-linked rapamycin analogs as mtor inhibitors
EP3674418A1 (en) * 2018-12-26 2020-07-01 Life Length S.L. Method for measuring telomere associated variables and uses thereof for the diagnosis and/or prognosis of telomeric-associated diseases
WO2021025935A1 (en) * 2019-08-02 2021-02-11 Georgetown University Dna-fish method for measurement of telomere length
AU2023275778A1 (en) 2022-05-25 2024-12-12 Revolution Medicines, Inc. Methods of treating cancer with an mtor inhibitor
CN117230169B (zh) * 2023-11-13 2024-02-13 元码基因科技(北京)股份有限公司 用于长片段端粒序列测序的接头、预文库及其构建方法
CN117248003B (zh) * 2023-11-13 2024-04-12 元码基因科技(北京)股份有限公司 用于完整端粒扩增子测序的组合物、预文库及其构建方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737454A (en) * 1983-07-14 1988-04-12 Molecular Diagnostics, Inc. Fast photochemical method of labelling nucleic acids for detection purposes in hybridization assays
US5489508A (en) * 1992-05-13 1996-02-06 University Of Texas System Board Of Regents Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
US5629154A (en) * 1993-11-12 1997-05-13 Geron Corporation Telomerase activity assays
IL107150A0 (en) * 1992-09-29 1993-12-28 Isis Pharmaceuticals Inc Oligonucleotides having a conserved g4 core sequence
WO1995013382A1 (en) * 1993-11-12 1995-05-18 Geron Corporation Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
JPH10507366A (ja) * 1994-10-21 1998-07-21 ゼネカ・リミテッド Pcrによるテロメアdnaの可変性の特性決定法

Similar Documents

Publication Publication Date Title
JP2000500033A5 (cg-RX-API-DMAC7.html)
JP2000500228A5 (cg-RX-API-DMAC7.html)
JP2000500445A5 (cg-RX-API-DMAC7.html)
JP2000500440A5 (cg-RX-API-DMAC7.html)
JP2000500327A5 (cg-RX-API-DMAC7.html)
JP2000500155A5 (cg-RX-API-DMAC7.html)
JP2000500406A5 (cg-RX-API-DMAC7.html)
JPH10507085A5 (cg-RX-API-DMAC7.html)
JP2000500361A5 (cg-RX-API-DMAC7.html)
JP2000509164A5 (cg-RX-API-DMAC7.html)
JP2000500322A5 (cg-RX-API-DMAC7.html)
JP2000500258A5 (cg-RX-API-DMAC7.html)
JP2000500342A5 (cg-RX-API-DMAC7.html)
JP2000500192A5 (cg-RX-API-DMAC7.html)
JP2000500226A5 (cg-RX-API-DMAC7.html)
JP2000500051A5 (cg-RX-API-DMAC7.html)
JP2000500407A5 (cg-RX-API-DMAC7.html)
JP2000500397A5 (cg-RX-API-DMAC7.html)
JP2000500019A5 (cg-RX-API-DMAC7.html)
JP2000500166A5 (cg-RX-API-DMAC7.html)
JP2000500044A5 (cg-RX-API-DMAC7.html)
JP2000500346A5 (cg-RX-API-DMAC7.html)
JP2000500257A5 (cg-RX-API-DMAC7.html)
JP2000500090A5 (cg-RX-API-DMAC7.html)
JP2000501035A5 (cg-RX-API-DMAC7.html)